Milestone Pharmaceuticals
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1111 Dr. Frederik-phillips Blvd Ste 420,...Phone Number
(514) 336-0444Website
www.milestonepharma.comRevenue
<$5 MillionStock Symbol
MISTIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Milestone Pharmaceuticals
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proof-of-concept trial for the treatment of patients with atrial fibrillation with rapid ventricular rate (AFib-RVR). Milestone Pharmaceuticals operates in Canada and the United States.Explore more
Milestone Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Milestone Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Milestone Pharmaceuticals has new funding data
Product Launch: Get notified when Milestone Pharmaceuticals launches new products
Milestone Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Milestone Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Milestone Pharmaceuticals had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Milestone Pharmaceuticals
Check out if Milestone Pharmaceuticals is spiking on competitors!
Earning: See what the market has to say on Milestone Pharmaceuticals recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Milestone Pharmaceuticals
Compare insights from companies similar to Milestone Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Milestone Pharmaceuticals is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Milestone Pharmaceuticals is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Milestone Pharmaceuticals.
Milestone Pharmaceuticals financials insights
Gather financial insights about Milestone Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Series A
$13M
2015
Series B
$17M
2017
Series C
$55M
2018
Series D
$80M
2019
Stock Offering
$94.9M
2020
Share Placement
$25M
2023
Other Financing Round
$125M
Milestone Pharmaceuticals Tech Stack
A closer look at the technologies used by Milestone Pharmaceuticals
See more technologies
Most Recent Scoops
Person-Based
Pharmaceuticals
Project
Laboratory Operations, Medical Research, Clinical Operations
Person-Based
HR Operations, Talent Management
Open Position
Open Position
Milestone Pharmaceuticals News & Media
Heart Rhythm Society and Milestone Pharmaceuticals Partner to Expand SVT Patient Education Through UpBeat.org
New resources launched in recognition of SVT Awareness Day - Wednesday June 3, 2026 WASHINGTON, June 1, 2026 /PRNewswire/ -- In recognition of SVT Awareness Day, the Heart Rhythm Society (HRS) and Milestone Pharmaceuticals are partnering to expand supraventricular tachycardia (SVT)...Milestone Pharmaceuticals to Present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
MONTREAL and CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that management will present at the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ to take place on Tuesday, May 19, 2026 in New York.Why Milestone Pharmaceuticals Stock Wilted on Wednesday
The biotech fell well short of analyst projections in the first quarter.Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call Transcript
Milestone Pharmaceuticals Inc. (MIST) Q1 2026 Earnings Call May 13, 2026 8:30 AM EDTCompany ParticipantsJoseph Oliveto - CEO, President & Executive...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Milestone Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Milestone Pharmaceuticals Inc. (Nasdaq: MIST), is a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines. Milestone's lead product candidate etripamil is currently in a Phase 3 clinical-stage program for the treatment of paroxysmal supraventricular tachycardia (PSVT) and in a Phase 2 proo... Read More
